Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. [electronic resource]
Producer: 20190807Description: 1-10 p. digitalISSN:- 1878-5905
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Chemoradiotherapy -- methods
- Cisplatin -- administration & dosage
- Drug Carriers
- Drug Synergism
- Female
- Humans
- Mice
- Nanoparticles -- chemistry
- Ovarian Neoplasms -- drug therapy
- Polyesters -- chemistry
- Polyethylene Glycols -- chemistry
- Wortmannin -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.